Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - BRAINSTORM CELL THERAPEUTICS INC. | Financial_Report.xls |
| 10-Q - FORM 10-Q - BRAINSTORM CELL THERAPEUTICS INC. | v409490_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - BRAINSTORM CELL THERAPEUTICS INC. | v409490_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - BRAINSTORM CELL THERAPEUTICS INC. | v409490_ex32-1.htm |
| EX-10.1 - EXHIBIT 10.1 - BRAINSTORM CELL THERAPEUTICS INC. | v409490_ex10-1.htm |
| EX-31.1 - EXHIBIT 31.1 - BRAINSTORM CELL THERAPEUTICS INC. | v409490_ex31-1.htm |
| EX-10.3 - EXHIBIT 10.3 - BRAINSTORM CELL THERAPEUTICS INC. | v409490_ex10-3.htm |
| EX-10.2 - EXHIBIT 10.2 - BRAINSTORM CELL THERAPEUTICS INC. | v409490_ex10-2.htm |
| EX-10.4 - EXHIBIT 10.4 - BRAINSTORM CELL THERAPEUTICS INC. | v409490_ex10-4.htm |
EXHIBIT 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying Quarterly Report on Form 10-Q of Brainstorm Cell Therapeutics Inc. for the period ended March 31, 2015, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
(1) such Quarterly Report on Form 10-Q for the period ended March 31, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2015 fairly presents, in all material respects, the financial condition and results of operations.
| May 14, 2015 | /s/ Alla Patlis |
| Name: Alla Patlis | |
|
Title: Interim Chief Financial Officer |